$PAGP

Plains GP (NYSE:PAGP) Stock Price Passes Below 50

Plains GP Holdings (NYSE:PAGP) fell below its 50-day moving average after Zacks Research downgraded the stock from “hold” to “strong sell.” The 50-day average is $24.07; shares traded as low as $23.05 and last at $23.35. MarketBeat shows a “Hold” consensus and $23.00 average target. The article also notes a $0.4175 quarterly dividend (7.1% yield).

Original reporting
Published Jun 25, 2026, 2:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 25, 2026, 2:56 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Plains GP (NYSE:PAGP) Stock Price Passes Below 50 — source image
Decision brief

The 30-second read

$PAGPBearishMed
01

Why it matters

A downgrade to strong sell can drive incremental selling and widen the gap between bullish and bearish research, while the technical break can amplify momentum/stop-loss activity.

02

Market read

Traders get a near-term catalyst (downgrade) plus a technical trigger (below 50-day MA) that can influence momentum and risk management decisions.

03

What to watch

The text highlights a high payout ratio (172.16%) and a 7.1% yield, which can attract income buyers even amid sell-side pressure; no new operational data is provided.

Relevance 6/10Novelty 5/10Timing: during Monday trading after the Zacks downgrade

Background

The piece frames PAGP’s technical move (below the 50-day MA) alongside a fresh sell-side downgrade and several recent analyst rating/target updates.

Company-level read

Ticker impact

$PAGPBearishMedium confidence
Context

PAGP shares fell below the 50-day moving average after Zacks downgraded the stock to a strong sell from hold.

Expected impact

Near-term downside bias; elevated volatility around further analyst revisions and dividend/coverage narratives.

Evidence & confidence

The article cites a specific downgrade (Zacks) and a concrete technical trigger (crossing below the 50-day MA), but provides no new fundamentals beyond analyst rating/target changes.

Market effects

Could modestly affect sentiment for midstream/pipeline peers if downgrades cluster, but the article is single-name focused.

No explicit regional catalyst; impact is primarily US-listed midstream sentiment.

Limited global relevance; no commodity, geopolitics, or cross-border deal details.

Counterpoint

Other firms in the article raised targets or maintained buy/neutral stances, suggesting the downgrade may be partially offset by competing research views.

Key entities

  • Plains GP Holdings, L.P.

    NYSE-listed pipeline general partner whose shares crossed below the 50-day moving average after a Zacks downgrade.

  • Zacks Research

    Downgraded PAGP from hold to strong sell, cited as the catalyst for the Monday move.

Related articles

$PAGPMed

Plains GP Holdings LP (PAGP) (Q2 2026) Earnings Call Highlights: Strong EBITDA

Plains GP Holdings LP (PAGP) reported Q2 2026 EBITDA of $690 million and said full-year 2026 EBITDA guidance remains unchanged, with the midpoint for the second half in the low $700 million range. Management cited $14 million in one-off environmental remediation costs, $40 million NGL adjusted EBITDA after a mid-May sale, and $50 million cost efficiencies targets for 2026 and 2027.

$PAGPMed

PLAINS GP HOLDINGS LP (PAGP): Completion of Acquisition or Disposition of Assets

PLAINS GP HOLDINGS LP (PAGP) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Exhibit 99.1 Plains All American Reports Second-Quarter 2026 Results Houston, TX – August 7, 2026 – Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP Holdings (Nasdaq: PAGP) today reported second-quarter 2026 results and provided the following highlights: Second-Quar

$PAAMedAI 8/10

Plains All American Pipeline, L.P.; Plains GP Holdings: Plains All American Reports Second-Quarter 2026 Results

Plains All American Pipeline (PAA) and Plains GP Holdings (PAGP) reported Q2 2026 results. PAA net income attributable to PAA was $1.830B, including about $1.6B from the Canadian NGL divestiture, and Adjusted EBITDA attributable to PAA was $738M. Pro forma leverage was 3.3x after ~$2.9B debt reduction. They paid a $0.4175/unit quarterly distribution and raised 2026 organic growth capex to $400-$450M.

$PAAMedAI 8/10

Plains All American Pipeline and Plains GP Holdings Provide Updated Capital Spending Guidance for 2026

Plains All American Pipeline (PAA) and Plains GP Holdings (PAGP) updated 2026 capital spending guidance. Growth capital is expected to rise to $400–$450 million net to PAA from about $350 million, while maintenance capital should stay near $185 million net to PAA. The increase is tied to Permian and Canadian growth projects, with a project update planned for August’s earnings call.

$PAGPMed

Plains GP (NYSE:PAGP) Downgraded by US Capital Advisors to Moderate Buy

US Capital Advisors downgraded Plains GP (NYSE:PAGP) from Strong Buy to Moderate Buy in a Friday research note, according to Zacks.com. Other firms adjusted targets: Stifel raised to $25, Morgan Stanley to $26, Citigroup to $23, and Truist initiated at $23. Consensus is Hold with a $22.50 target. PAGP opened at $24.35; it paid a $0.4175 quarterly dividend (6.9% yield).